Norcliffe Capital works closely with financial advisers, wealth managers, family offices, private banks and accountants to provide tax efficient investments focused on new advances in technology.
We take exceptional care in the choice of our investments, only supporting those that meet our investment mandate.
Investment can be made in tax efficient ways via the Enterprise Investment Scheme. You can also use a SIPP, SSAS or a family investment company to access our investments, with the provision of EIS3 certificates a priority.
We offer a simple fee structure for advised or directly referred clients that ensures all parties benefit from a positive investment outcome.
Adviser’s appreciate Norcliffe Capital’s regular and transparent communications.
With decades of combined business experience in the life science sectors, Norcliffe Capital provides the opportunity to invest in companies that will change people’s lives and that fulfil our mandate of investing for profit with a purpose.
The Norcliffe Capital team is a diverse network of consultants and industry professionals with a global mindset and a collaborative culture. We work to understand your issues and are driven to ask better questions in the pursuit of making your business work better.
Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk.
What are the key risks?
If you are interested in learning more about how to protect yourself, visit the FCA’s website here.